To begin our considerations, I would like to draw your attention to a recent article in New Scientist by Clare Wilson. In the article entitled Out of the Shadows, Wilson discusses aspects of the most recent thinking on schizophrenia. In the course of discussing the case of Peter Bullimore, a recovered schizophrenic, she points out that,
“The downsides [of medication] have always been seen as a necessary price to pay for relief from the condition’s devastating symptoms, but now that idea is being called into question. Not only are the side effects of these drugs worse than we thought; the benefits are also smaller.”
Come along to The Counting House at 7pm for a talk by Kenneth. Share a crust of bread, and hear the reflections he has to share…
Title of talk:
Schizophrenia: Reflections by an Insider
Bullet points of what you would like to talk about:
1. I’ll begin by introducing concerns over the viability of ‘schizophrenia’ as a term. The condition that this traditional term refers to is real, in my opinion, but the term comes with so much stigma that the diagnosis is almost as bad as the condition itself – therefore I’d like to advocate a much less stigma-laden term. I don’t know what the new term is to be but I think we need one.